BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 29459014)

  • 21. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
    Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
    J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage.
    Robinson WP; Owens CD; Nguyen LL; Chong TT; Conte MS; Belkin M
    J Vasc Surg; 2009 Jun; 49(6):1416-25. PubMed ID: 19497500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Black patients present with more severe vascular disease and a greater burden of risk factors than white patients at time of major vascular intervention.
    Soden PA; Zettervall SL; Deery SE; Hughes K; Stoner MC; Goodney PP; Vouyouka AG; Schermerhorn ML;
    J Vasc Surg; 2018 Feb; 67(2):549-556.e3. PubMed ID: 28951156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Hispanic Black and Hispanic Patients Have Worse Outcomes Than White Patients Within Similar Stages of Peripheral Artery Disease.
    Kalbaugh CA; Witrick B; Sivaraj LB; McGinigle KL; Lesko CR; Cykert S; Robinson WP
    J Am Heart Assoc; 2022 Jan; 11(1):e023396. PubMed ID: 34927446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Race with Long-Term Outcomes in Patients Undergoing Popliteal and Infra-Popliteal Percutaneous Peripheral Arterial Interventions.
    Alasaad M; Zaitoun A; Szpunar S; Lalonde T; Rosman HS; Mehta RH; Yamasaki H; Othman H
    Cardiovasc Revasc Med; 2019 Aug; 20(8):649-653. PubMed ID: 30401590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.
    Chen SL; Whealon MD; Kabutey NK; Kuo IJ; Sgroi MD; Fujitani RM
    J Vasc Surg; 2017 Jun; 65(6):1680-1689. PubMed ID: 28527930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High hemoglobin A
    Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
    J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Black patients have a higher burden of comorbidities but a lower risk of 30-day and 1-year mortality after thoracic endovascular aortic repair.
    Yin K; AlHajri N; Rizwan M; Locham S; Dakour-Aridi H; Malas MB
    J Vasc Surg; 2021 Jun; 73(6):2071-2080.e2. PubMed ID: 33278540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary outcomes of limb-salvage procedures using Vascular Quality Initiative-Medicare-linked data: Racial and ethnic disparities persist.
    Mathlouthi A; Zarrintan S; Khan MA; Malas M; Barleben A
    J Vasc Surg; 2022 Jun; 75(6):2013-2018. PubMed ID: 35149160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia.
    Hicks CW; Najafian A; Farber A; Menard MT; Malas MB; Black JH; Abularrage CJ
    J Vasc Surg; 2016 Dec; 64(6):1667-1674.e1. PubMed ID: 27871493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes in diabetic patients with chronic limb-threatening ischemia.
    Liang P; Soden PA; Zettervall SL; Shean KE; Deery SE; Guzman RJ; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2018 Aug; 68(2):487-494. PubMed ID: 29576404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations.
    Darling JD; McCallum JC; Soden PA; Guzman RJ; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
    J Vasc Surg; 2017 Mar; 65(3):695-704. PubMed ID: 28073665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nationwide Trends in Hospital Outcomes and Utilization After Lower Limb Revascularization in Patients on Hemodialysis.
    Garimella PS; Balakrishnan P; Correa A; Poojary P; Annapureddy N; Chauhan K; Patel A; Patel S; Konstantinidis I; Chan L; Agarwal SK; Jaar BG; Gidwani U; Matsushita K; Nadkarni GN
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2101-2110. PubMed ID: 29050629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distal anastomotic vein adjunct usage in infrainguinal prosthetic bypasses.
    McPhee JT; Goodney PP; Schanzer A; Shaykevich S; Belkin M; Menard MT
    J Vasc Surg; 2013 Apr; 57(4):982-9. PubMed ID: 23375606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cilostazol and freedom from amputation after lower extremity revascularization.
    Neel JD; Kruse RL; Dombrovskiy VY; Vogel TR
    J Vasc Surg; 2015 Apr; 61(4):960-4. PubMed ID: 25595396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia between patients with and without diabetes.
    Darling JD; Bodewes TCF; Deery SE; Guzman RJ; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
    J Vasc Surg; 2018 Apr; 67(4):1159-1169. PubMed ID: 28947228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia.
    Okazaki J; Matsuda D; Tanaka K; Ishida M; Kuma S; Morisaki K; Furuyama T; Maehara Y
    J Vasc Surg; 2018 Mar; 67(3):817-825. PubMed ID: 29032905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of isolated tibial disease on outcomes in the critical limb ischemic population.
    Gray BH; Grant AA; Kalbaugh CA; Blackhurst DW; Langan EM; Taylor SA; Cull DL
    Ann Vasc Surg; 2010 Apr; 24(3):349-59. PubMed ID: 20045628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wound location is independently associated with adverse outcomes following first-time revascularization for tissue loss.
    Darling JD; O'Donnell TFX; Vu GH; Norman AV; St John E; Stangenberg L; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2021 Apr; 73(4):1320-1331. PubMed ID: 32866559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization.
    Kray JE; Dombrovskiy VY; Vogel TR
    Vasc Health Risk Manag; 2017; 13():269-274. PubMed ID: 28761352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.